Neuros Medical

Neuros Medical is a neurotechnology company headquartered in Willoughby Hills, Ohio, focused on developing advanced neuromodulation solutions for patients suffering from debilitating nerve pain following amputation. The company's flagship product, the HALO system, is a high-frequency nerve block neurostimulator designed to non-destructively silence peripheral nerve activity, effectively interrupting the aberrant pain signals responsible for phantom limb pain. Unlike traditional approaches that may damage nerve tissue or rely on systemic pharmacological treatments, the HALO system offers a targeted, reversible intervention delivered directly at the peripheral nerve. This positions Neuros Medical at the forefront of a growing effort to address unmet clinical needs in chronic pain management through precision neuromodulation.

Neuros Medical has advanced its technology through rigorous clinical development, building a body of evidence supporting the safety and efficacy of high-frequency peripheral nerve stimulation for post-amputation pain. The company has secured over 55 million dollars in Series C funding, reflecting strong investor confidence in both its technology platform and the scale of the commercial opportunity. This capital has supported expanded clinical trials and the continued refinement of the HALO system ahead of broader regulatory and commercial milestones. The progress Neuros Medical has achieved positions it as one of the more clinically mature companies working specifically on peripheral neuromodulation for amputation-related conditions.

Neuros Medical represents a meaningful advancement in the neurotech industry's broader effort to move beyond generalized pain management toward highly specific, mechanism-driven therapies. Phantom limb pain affects a significant portion of the amputee population and remains notoriously difficult to treat with conventional interventions, creating a substantial unmet medical need that the company is uniquely positioned to address. By demonstrating that peripheral nerve block technology can be delivered safely and effectively through an implantable platform, Neuros Medical is helping to expand the therapeutic frontier of neuromodulation beyond the central nervous system. Their work may also inform future applications of high-frequency nerve block technology across other chronic pain indications, amplifying their long-term significance to the field.